Premium
Digoxin doses over 125μg daily in vulnerable patient groups
Author(s) -
Spencer Rachel,
Serumaga Brian
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.841
Subject(s) - medicine , audit , digoxin , interface (matter) , clinical practice , family medicine , accounting , computer science , heart failure , bubble , maximum bubble pressure method , parallel computing , business
In this series we present a number of prescribing safety indicators developed as part of an RCGP project. 1 The evidence base behind each of the indicators is given along with information to illustrate their clinical significance. We provide a ‘real‐life’ audit based on the indicator to show how practices could begin to analyse their own prescribing data. Copyright © 2011 Wiley Interface Ltd
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom